Wellnex Life (ASX:WNX) 5-Year EBITDA Growth Rate: 43.10% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Wellnex Life 5-Year EBITDA Growth Rate?

Wellnex Life ASX:WNX 5-Year EBITDA Growth Rate is 43.10% as of Dec. 2025. The stock has 2 warning signs investors should review.

Wellnex Life's EBITDA per Share for the six months ended in Dec. 2025 was A$-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 18.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 43.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Wellnex Life was 50.70% per year. The lowest was -76.60% per year. And the median was 21.55% per year.


Wellnex Life  (ASX:WNX) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Wellnex Life 5-Year EBITDA Growth Rate Related Terms


ASX:WNX vs KHC, GIS: 5-Year EBITDA Growth Rate Comparison

For the Packaged Foods subindustry, Wellnex Life's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wellnex Life 5-Year EBITDA Growth Rate vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Wellnex Life's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Wellnex Life's 5-Year EBITDA Growth Rate falls into.



Wellnex Life 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 43.10% mean?
Wellnex Life (ASX:WNX) has a 5-Year EBITDA Growth Rate of 43.10% as of Dec. 2025. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Wellnex Life and its competitors.
Is Wellnex Life's 5-Year EBITDA Growth Rate too high?
Wellnex Life's current 5-Year EBITDA Growth Rate is 43.10%.
How does Wellnex Life's 5-Year EBITDA Growth Rate compare to KHC and GIS?
Wellnex Life's 5-Year EBITDA Growth Rate of 43.10% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Consumer Packaged Goods company?
A good 5-Year EBITDA Growth Rate depends on the Consumer Packaged Goods industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Wellnex Life and its competitors. Wellnex Life's current 5-Year EBITDA Growth Rate is 43.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellnex Life stock overvalued right now?
Based on GuruFocus' analysis, Wellnex Life (ASX:WNX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.35, compared to a current price of A$0.06 — trading 84.3% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 43.10%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Wellnex Life (ASX:WNX), the current 5-Year EBITDA Growth Rate is 43.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Wellnex Life Business Description

Other Exchanges WNX:UK22W0:Germany
Address 574 Plummer Street, Building 2, Level 3, Suite 72, Port Melbourne, Melbourne, VIC, AUS, 3207
Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group's offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.